JP Morgan Chase
JAZZ icon

JP Morgan Chase’s Jazz Pharmaceuticals JAZZ Stock Holding History

JP Morgan Chase’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-27,200
Closed -$3.35M – 7642
2023
Q4 		$3.35M Buy
+27,200
New +$3.39M ﹤0.01% 3435
2021
Q2 		– Sell
-25,000
Closed -$4.11M – 6464
2021
Q1 		$4.11M Sell
25,000
-40,000
-62% -$6.58M ﹤0.01% 3140
2020
Q4 		$10.7M Buy
65,000
+32,600
+101% +$4.86M ﹤0.01% 2157
2020
Q3 		$4.53M Buy
+32,400
New +$4.02M ﹤0.01% 2650
2018
Q3 		– Sell
-70,000
Closed -$12.1M – 5736
2018
Q2 		$12.1M Buy
70,000
+30,000
+75% +$4.9M ﹤0.01% 1987
2018
Q1 		$6.04M Buy
+40,000
New +$5.87M ﹤0.01% 2413
2017
Q4 		– Sell
-30,000
Closed -$4.44M – 5505
2017
Q3 		$4.44M Buy
+30,000
New +$4.54M ﹤0.01% 2646
2017
Q2 		– Sell
-27,000
Closed -$3.92M – 5083
2017
Q1 		$3.92M Buy
+27,000
New +$3.52M ﹤0.01% 2608
2015
Q3 		– Sell
-2,675
Closed -$471K – 3997
2015
Q2 		$471K Sell
2,675
-27,325
-91% -$4.91M ﹤0.01% 3577
2015
Q1 		$5.18M Buy
+30,000
New +$5.15M ﹤0.01% 2324
2014
Q4 		– Sell
-910,000
Closed -$146M – 4285
2014
Q3 		$146M Buy
+910,000
New +$140M 0.03% 500

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

JP Morgan Chase's JAZZ Position: Q2 2026 in Review

JP Morgan Chase reduced its Jazz Pharmaceuticals (JAZZ) stake by 3.6% in Q2 2026, selling an estimated $9.54M and leaving 1,160,786 shares worth $277M. The position accounts for 0.02% of the portfolio, ranked #638.

JP Morgan Chase first reported a position in JAZZ in Q2 2013 and has held it in 53 quarters since. The position peaked at $527M in Q2 2022. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • JP Morgan Chase held 1,160,786 shares of Jazz Pharmaceuticals worth $277M as of Q2 2026.
  • JP Morgan Chase sold 43,567 Jazz Pharmaceuticals shares in Q2 2026, an estimated $9.54M.
  • Jazz Pharmaceuticals made up 0.02% of JP Morgan Chase's portfolio in Q2 2026, its #638 holding.
  • JP Morgan Chase first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Jazz Pharmaceuticals position peaked at $527M in Q2 2022.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.